推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Journal of Thoracic Oncology

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J THORAC ONCOL最新评论:咋能咋样,肯定拒稿的 (2022-11-30)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


Journal of Thoracic Oncology期刊基本信息Hello,您是该期刊的第56674位访客


基本信息 登录收藏
期刊名字Journal of Thoracic OncologyJournal of Thoracic Oncology

J THORAC ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
9.2
50人评分
我要评分

声誉
9.9

影响力
8.6

速度
9.4

期刊ISSN1556-0864
微信扫码收藏此期刊
E-ISSN1556-1380
2022-2023最新影响因子
(数据来源于搜索引擎)
20.4 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:16.262
2022-2023自引率3.90%点击查看自引率趋势图
五年影响因子16.7
h-index 113
CiteScore
CiteScoreSJRSNIPCiteScore排名
31.905.8663.593
学科分区排名百分位
大类:Medicine
小类:Pulmonary and Respiratory Medicine
Q12 / 144
大类:Medicine
小类:Oncology
Q112 / 366

期刊简介
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology.
期刊官方网站http://www.jto.org/
期刊投稿网址https://www.editorialmanager.com/JTO
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Journal of Thoracic Oncology的语言要求,还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621
出版商International Association for the Study of Lung Cancer
涉及的研究方向医学-呼吸系统
出版国家或地区UNITED STATES
出版语言English
出版周期Monthly
出版年份2006
年文章数 91点击查看年文章数趋势图
Gold OA文章占比34.02%
研究类文章占比:
文章 ÷(文章 + 综述)
87.91%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:1区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q113/241
学科:RESPIRATORY SYSTEM
类别:SCIE
Q14/65
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区4区
ONCOLOGY
肿瘤学
1区3区1区
RESPIRATORY SYSTEM
呼吸系统
3区2区1区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区1区
ONCOLOGY
肿瘤学
1区1区1区
RESPIRATORY SYSTEM
呼吸系统
1区1区1区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
ONCOLOGY
肿瘤学
1区4区1区
RESPIRATORY SYSTEM
呼吸系统
3区4区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D
平均审稿速度网友分享经验:
一般,3-6周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Journal of Thoracic Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Journal of Thoracic Oncology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Journal of Thoracic Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE34328.70
    EUROPEAN RESPIRATORY JOURNAL21625.30
    THORAX20014.30
    CHEST26711.90
    JOURNAL OF HEART AND LUNG TRANSPLANTATION12211.70
    RESPIROLOGY729.40
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY14711.70
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY18010.50
    Paediatric Respiratory Reviews559.50
    RESPIRATORY RESEARCH959.50
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE616665
    BIOMATERIALS524491
    BIOMEDICINE & PHARMACOTHERAPY481259
    Journal of Materials Chemistry B468354
    Frontiers in Pharmacology463665
    Frontiers in Immunology436684
    JOURNAL OF ETHNOPHARMACOLOGY417606
    COLLOIDS AND SURFACES B-BIOINTERFACES411164
    Frontiers in Oncology395184
    COMPUTERS IN BIOLOGY AND MEDICINE387596
  •  

    Journal of Thoracic Oncology Journal of Thoracic Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC

    Author: Naidoo, Jarushka; Antonia, Scott; Wu, Yi-Long; Cho, Byoung Chul; Thiyagarajah, Piruntha; Mann, Helen; Newton, Michael; Faivre-Finn, Corinne
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 5, pp. 657-663. DOI: 10.1016/j.jtho.2023.02.009
        PubMed      DOI
    2.Tislelizumab Versus Docetaxel in Patients With Previously Treated Advanced NSCLC (RATIONALE-303): A Phase 3, Open-Label, Randomized Controlled Trial

    Author: Zhou, Caicun; Huang, Dingzhi; Fan, Yun; Yu, Xinmin; Liu, Yunpeng; Shu, Yongqian; Ma, Zhiyong; Wang, Ziping; Cheng, Ying; Wang, Jie; Hu, Sheng; Liu, Zhihua; Poddubskaya, Elena; Disel, Umut; Akopov, Andrey; Dvorkin, Mikhail; Zheng, Wenjuan; Ma, Yiyuan; Wang, Yan; Li, Songzi; Yu, Cunjing; Rivalland, Gareth
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 1, pp. 93-105. DOI: 10.1016/j.jtho.2022.09.217
        PubMed      DOI
    3.NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC

    Author: de Castro Jr, Gilberto; Rizvi, Naiyer A.; Schmid, Peter; Syrigos, Konstantinos; Martin, Claudio; Yamamoto, Nobuyuki; Cheng, Ying; Moiseyenko, Vladimir; Summers, Yvonne; Vynnychenko, Ihor; Lee, Sung Yong; Bryl, Maciej; Zer, Alona; Erman, Mustafa; Timcheva, Constanta; Raja, Rajiv; Naicker, Kirsha; Scheuring, Urban; Walker, Jill; Mann, Helen; Chand, Vikram; Mok, Tony
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 1, pp. 106-119. DOI: 10.1016/j.jtho.2022.09.223
        PubMed      DOI
    4.Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b Trial

    Author: Yan, Wanpu; Zhong, Wen-Zhao; Liu, Yan-Hui; Chen, Qixun; Xing, Wenqun; Zhang, Qin; Liu, Lunxu; Ge, Di; Chen, Keneng; Yang, Fan; Lin, Xiang; Song, Li; Shi, Wei; Wu, Yi-Long
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 2, pp. 194-203. DOI: 10.1016/j.jtho.2022.09.222
        PubMed      DOI
    5.First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations

    Author: Paz-Ares, Luis G.; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Bennouna, Jaafar; Schenker, Michael; Cheng, Ying; Juan-Vidal, Oscar; Mizutani, Hideaki; Lingua, Alejo; Reyes-Cosmelli, Felipe; Reinmuth, Niels; Menezes, Juliana; Jassem, Jacek; Protsenko, Svetlana; Richardet, Eduardo; Felip, Enriqueta; Feeney, Kynan; Zurawski, Bogdan; Alexandru, Aurelia; Jimenez, Emmanuel de la Mora; Dakhil, Shaker; Lu, Shun; Reck, Martin; John, Thomas; Hu, Nan; Zhang, Xiaoqing; Sylvester, Judi; Eccles, Laura J.; Grootendorst, Diederik J.; Balli, David; Neely, Jaclyn; Carbone, David P.
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 2, pp. 204-222. DOI: 10.1016/j.jtho.2022.10.014
        DOI
    6.PTEN Loss Expands the Histopathologic Diversity and Lineage Plasticity of Lung Cancers Initiated by Rb1/Trp53 Deletion

    Author: Zhang, Letian; Zhu, Xiang; Liu, Congrong; Zhang, Bo; Zheng, Jie; Singh, Prashant K.; Bshara, Wiam; Wang, Jianmin; Gomez, Eduardo Cortes; Zhang, Xiaojing; Wang, Yanqing; Goodrich, David W.
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 3, pp. 324-338. DOI: 10.1016/j.jtho.2022.11.019
        PubMed      DOI
    7.Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium

    Author: Garcia-Pardo, Miguel; Chang, Amy; Schmid, Sabine; Dong, Mei; Brown, M. Catherinen; Christiani, David; Tindel, Hilary Aurora; Brennan, Paul; Chen, Chu; Zhang, Jie; Ryan, Brid M.; Zaridze, David; Schabath, Matthew B.; Leal, Leticia Ferro; Reis, Rui Manuel; Tardon, Adonina; Fernandez-Tardon, Guillermo; Shete, Sanjay S.; Andrew, Angeline; Brenner, Hermann; Xu, Wei; Hung, Rayjean J.; Liu, Geoffrey
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 3, pp. 313-323. DOI: 10.1016/j.jtho.2022.10.020
        PubMed      DOI
    8.Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee

    Author: Thunnissen, Erik; Beasley, Mary Beth; Borczuk, Alain; Dacic, Sanja; Kerr, Keith M.; Lissenberg-Witte, Birgit; Minami, Yuko; Nicholson, Andrew G.; Noguchi, Masayuki; Sholl, Lynette; Tsao, Ming-Sound; Le Quesne, John; Roden, Anja C.; Chung, Jin-Haeng; Yoshida, Akihiko; Moreira, Andre L.; Lantuejoul, Sylvie; Pelosi, Giuseppe; Poleri, Claudia; Hwang, David; Jain, Deepali; Travis, William D.; Brambilla, Elisabeth; Chen, Gang; Botling, Johan; Bubendorf, Lukas; Mino-Kenudson, Mari; Motoi, Noriko; Chou, Teh Ying; Papotti, Mauro; Yatabe, Yasushi; Cooper, Wendy; Invasion Working Group
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 4, pp. 447-462. DOI: 10.1016/j.jtho.2022.11.026
        PubMed      DOI
    9.Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

    Author: Mitsudomi, Tetsuya; Tan, Daniel; Yang, James Chih-Hsin; Ahn, Myung-Ju; Batra, Ullas; Cho, Byoung-Chul; Cornelio, Gerardo; Lim, Tony; Mok, Tony; Prabhash, Kumar; Reungwetwattana, Thanyanan; Ren, Sheng-Xiang; Singh, Navneet; Toyooka, Shinichi; Wu, Yi-Long; Yang, Pan-Chyr; Yatabe, Yasushi
    Journal: JOURNAL OF THORACIC ONCOLOGY. 2023; Vol. 18, Issue 4, pp. 436-446. DOI: 10.1016/j.jtho.2022.10.021
        PubMed      DOI
    10.Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With Lung Adenocarcinoma

    Author: Zhihua Gong, Qingzhu Jia, Junying Chen, Xinwei Diao, Jianbao Gao, Xinxin Wang, Bo Zhu
    Journal: Journal of Thoracic Oncology, 2019, Vol., , DOI:10.1016/j.jtho.2019.01.024
        DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386164.40
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE REVIEWS MICROBIOLOGY25060.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共45条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451